Investors saw multiple shades of red in the stock market today. But some sectors showed strength. Beazer Homes broke out on earnings and ran past a new buy point of 35.20 in a seven-week base. Some ...
Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.
Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...